SS Innovations International (NASDAQ:SSII – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare SS Innovations International to similar businesses based on the strength of its earnings, valuation, profitability, risk, analyst recommendations, institutional ownership and dividends.
Risk and Volatility
SS Innovations International has a beta of -1.52, indicating that its stock price is 252% less volatile than the S&P 500. Comparatively, SS Innovations International’s competitors have a beta of 2.57, indicating that their average stock price is 157% more volatile than the S&P 500.
Institutional & Insider Ownership
40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Profitability
This table compares SS Innovations International and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SS Innovations International | -23.73% | -26.77% | -15.01% |
| SS Innovations International Competitors | -304.20% | -315.07% | -22.11% |
Earnings & Valuation
This table compares SS Innovations International and its competitors top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| SS Innovations International | $52.40 million | -$12.13 million | -25.17 |
| SS Innovations International Competitors | $1.90 billion | $136.31 million | 5.82 |
SS Innovations International’s competitors have higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Analyst Recommendations
This is a breakdown of current recommendations and price targets for SS Innovations International and its competitors, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SS Innovations International | 1 | 0 | 0 | 0 | 1.00 |
| SS Innovations International Competitors | 4291 | 10577 | 18359 | 831 | 2.46 |
SS Innovations International currently has a consensus target price of $7.00, indicating a potential upside of 363.58%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 20.49%. Given SS Innovations International’s higher possible upside, analysts plainly believe SS Innovations International is more favorable than its competitors.
Summary
SS Innovations International competitors beat SS Innovations International on 9 of the 13 factors compared.
SS Innovations International Company Profile
SS Innovations International is a medical technology company focused on developing and manufacturing surgical robotic systems. Its flagship product, the SSI Mantra, is a multi-arm platform designed to support surgeons during minimally invasive procedures. The company’s offerings include surgical instruments and related technologies, such as its SSI Mudra instruments, as well as training and support services for hospitals and clinicians. The SSI Mantra system is designed with features including a surgeon console and 3D visualization, and the company has also emphasized remote surgery and telementoring capabilities.
Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.
